Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Karpel (Great Neck, United States of America), S. Carey (Woking, Surrey, United Kingdom), M. Humbert (Clamart, France). Omalizumab in practice: learning from experience. Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives

Member's Comments

No comment yet.

Related content which might interest you: Anti-IgE: changing lives in clinical practice? Source: Eur Respir Rev 2007; 16: 59-60 Year: 2007 Use of Omalizumab in children in real clinical practice. Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Switch Omalizumab – Mepolizumab: real life experience Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Pirfenidone: an update on clinical trial data and insights from everyday practice Source: Eur Respir Rev 2014; 23: 111-117 Year: 2014 Knowledge and skills for inhaled drugs before and after a rehabilitation program in COPD: a real life study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Adherence to asthma treatment: Can it be improved in general practice? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Treatment of childhood asthma in Malaysia: adherence of general practice preferences to clinical practice guidelines Source: Eur Respir J 2002; 20: Suppl. 38, 332s Year: 2002 The professional perspective: responding to the patient’s experience Source: International Congress 2014 – ELF/ERS session: improving CPAP and NIV - a user perspective Year: 2014 Is simulation based training in inhaler technique of health care professionals more effective than written information?: A randomised controlled study Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Italian real-life experience of omalizumab Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Risk communication in mild asthma: learning from other disciplines Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Remote asthma reviews: Developing practice resources for the IMP2ART trial. Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 Implementation of evidence-based care in physiotherapy: Putting theory into practice in physiotherapy rehabilitation Source: Annual Congress 2003 - Implementation of evidence-based care in Allied Respiratory Professionals Year: 2003 Anti-IgE therapy: current knowledge and future perspective Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Principles of teaching and learning in the clinical workplace Source: Annual Congress 2012 - PG20 European spirometry train-the-trainer programme Year: 2012